Lewis Cantley, Ph.D. (Chair)

Dr. Cantley is a co-founder of Volastra and a world-renowned biologist and biochemist. He is celebrated, in particular, for his discovery of the phosphoinositide 3-kinase (PI3K) signaling pathway in the 1980s. Dr. Cantley’s lab at Weill Cornell Medical College investigates cancer metabolism and phosphoinositide signaling and was the first lab to identify the link between chromosomal instability and cytosolic DNA signaling in cancer metastases.